[Combating the new influenza A (H1N1) virus. I. Overview of the relevant virological aspects].
In April 2009 a new influenza virus was discovered, which spread from Mexico to the rest of the world. The new influenza A (H1N1) virus is genetically related to swine flu viruses, and differs substantially from circulating human influenza viruses. It is able to spread from person to person. Because it is a completely new virus, there is probably little immunity in the population. The course of the infection is relatively mild, but the virus will mutate and it is not yet certain whether this will affect severity of the influenza. General practitioners have an important role in surveillance and treatment. The Community Health Services must be notified of any patients who are suspected of having the new influenza. Hygiene measures and administration of antiviral drugs to patients and their contacts may slow the spread. A delay in large-scale spread in the Netherlands allows time for the development of vaccines.
Koopmans
Marion P G
MP
Rijksinstituut voor Volksgezondheid en Milieu, Bilthoven, The Netherlands.
Meijer
Adam
A
van der Lubben
Mariken I M
MI
Boucher
Charles
C
Fouchier
Ron A M
RA
Osterhaus
Ab D M E
AD
Timen
Aura
A
de Jong
Menno D
MD
van Steenbergen
Jim E
JE
D000998:Antiviral Agents / Q000627:therapeutic use*; D003153:Community Health Services; D006801:Humans; D006920:Hygiene; D053118:Influenza A Virus, H1N1 Subtype / Q000472:pathogenicity*; D007252:Influenza Vaccines; D007251:Influenza, Human / Q000276:immunology / Q000517:prevention & control* / Q000821:virology*; D009426:Netherlands
D000998:Antiviral Agents; D007252:Influenza Vaccines